Exchange Announcement • 22 May 2026 13:00
Exchange Announcement • 21 May 2026 17:00
Exchange Announcement • 12 May 2026 18:45
Exchange Announcement • 30 Apr 2026 15:30
Exchange Announcement • 29 Apr 2026 17:00
𝛼SK or SearchENTITY
HUTCHMED (HCM LN)
HUTCHMED (HCM LN)
26
Analysis
Health Care • Hong Kong
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has established a fully integrated R&D platform and a profitable commercial platform in China. It is headquartered in Hong Kong and was founded in 2000.
morex